da Silva Jorge Santos

Director, Chief Executive Officer · 1 filing · Latest: Apr 10, 2026

MoonLake Immunotherapeutics

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MLTX	da Silva Jorge Santos	Director, Chief Executive Officer	Apr 13, 2026	Sale	$18.23	51,873	$945.6K	2,924,893	Apr 14 5:55 PM
MLTX	da Silva Jorge Santos	Director, Chief Executive Officer	Apr 10, 2026	Sale	$18.41	98,127	$1.8M	2,976,766	Apr 14 5:55 PM